| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.53e-07 | 37 | 133 | 6 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.28e-05 | 127 | 133 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | helicase activity | 9.19e-05 | 158 | 133 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.77e-04 | 262 | 133 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type I | 4.35e-04 | 5 | 133 | 2 | GO:0005025 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 4.67e-04 | 206 | 133 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | K63-linked polyubiquitin modification-dependent protein binding | 6.71e-04 | 26 | 133 | 3 | GO:0070530 | |
| MousePheno | abnormal embryonic tissue cell apoptosis | RAF1 AHCTF1 CHD8 CHD1 NCAPG2 THOC6 BMPR1A ZPR1 KDM2B DDX11L8 | 1.78e-06 | 180 | 112 | 10 | MP:0013503 |
| MousePheno | abnormal embryonic tissue physiology | RAF1 AHCTF1 CHD8 CHD1 NCAPG2 THOC6 BMPR1A ZPR1 KDM2B ADAMTS20 DDX11L8 | 2.59e-05 | 297 | 112 | 11 | MP:0008932 |
| Domain | SNF2_N | 8.66e-08 | 32 | 132 | 6 | IPR000330 | |
| Domain | SNF2_N | 8.66e-08 | 32 | 132 | 6 | PF00176 | |
| Domain | BRK | 6.80e-06 | 6 | 132 | 3 | SM00592 | |
| Domain | BRK_domain | 6.80e-06 | 6 | 132 | 3 | IPR006576 | |
| Domain | BRK | 6.80e-06 | 6 | 132 | 3 | PF07533 | |
| Domain | Chromo_domain | 2.27e-05 | 24 | 132 | 4 | IPR023780 | |
| Domain | Chromo | 3.16e-05 | 26 | 132 | 4 | PF00385 | |
| Domain | CHROMO_1 | 4.28e-05 | 28 | 132 | 4 | PS00598 | |
| Domain | CHROMO_2 | 4.28e-05 | 28 | 132 | 4 | PS50013 | |
| Domain | Chromodomain-like | 7.35e-05 | 32 | 132 | 4 | IPR016197 | |
| Domain | Chromo/shadow_dom | 8.32e-05 | 33 | 132 | 4 | IPR000953 | |
| Domain | CHROMO | 8.32e-05 | 33 | 132 | 4 | SM00298 | |
| Domain | Helicase_C | 1.12e-04 | 107 | 132 | 6 | PF00271 | |
| Domain | HELICc | 1.12e-04 | 107 | 132 | 6 | SM00490 | |
| Domain | Helicase_C | 1.18e-04 | 108 | 132 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 1.24e-04 | 109 | 132 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.24e-04 | 109 | 132 | 6 | PS51192 | |
| Domain | DEXDc | 1.24e-04 | 109 | 132 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.31e-04 | 110 | 132 | 6 | IPR014001 | |
| Domain | - | 2.95e-04 | 4 | 132 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 2.95e-04 | 4 | 132 | 2 | PS51139 | |
| Domain | GTF2I | 2.95e-04 | 4 | 132 | 2 | PF02946 | |
| Domain | GTF2I | 2.95e-04 | 4 | 132 | 2 | IPR004212 | |
| Domain | ARM-type_fold | 6.90e-04 | 339 | 132 | 9 | IPR016024 | |
| Domain | GS_dom | 1.02e-03 | 7 | 132 | 2 | IPR003605 | |
| Domain | GS | 1.02e-03 | 7 | 132 | 2 | PS51256 | |
| Domain | TGF_beta_GS | 1.02e-03 | 7 | 132 | 2 | PF08515 | |
| Domain | GS | 1.02e-03 | 7 | 132 | 2 | SM00467 | |
| Domain | Znf_RING/FYVE/PHD | TRIM25 TRIM42 ZFYVE16 FANCL LTN1 KDM2B KDM7A WDFY3 SYVN1 TOPORS | 1.58e-03 | 459 | 132 | 10 | IPR013083 |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.91e-03 | 35 | 132 | 3 | IPR002464 | |
| Domain | Activin_recp | 2.15e-03 | 10 | 132 | 2 | PF01064 | |
| Domain | Activin_recp | 2.15e-03 | 10 | 132 | 2 | IPR000472 | |
| Domain | Pkinase_Tyr | 2.23e-03 | 129 | 132 | 5 | PF07714 | |
| Domain | DEAH_ATP_HELICASE | 2.43e-03 | 38 | 132 | 3 | PS00690 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.99e-03 | 138 | 132 | 5 | IPR001245 | |
| Domain | ARM-like | 3.11e-03 | 270 | 132 | 7 | IPR011989 | |
| Domain | TGFB_receptor | 3.12e-03 | 12 | 132 | 2 | IPR000333 | |
| Domain | SH3 | 4.37e-03 | 216 | 132 | 6 | SM00326 | |
| Domain | SH3 | 4.37e-03 | 216 | 132 | 6 | PS50002 | |
| Domain | - | 4.65e-03 | 449 | 132 | 9 | 3.30.40.10 | |
| Domain | SH3_domain | 4.78e-03 | 220 | 132 | 6 | IPR001452 | |
| Domain | Spectrin_alpha_SH3 | 4.90e-03 | 15 | 132 | 2 | IPR013315 | |
| Pubmed | 1.17e-08 | 20 | 134 | 5 | 12743021 | ||
| Pubmed | 1.82e-07 | 64 | 134 | 6 | 22261194 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | WASHC4 QPCTL COPB1 PROCR AHCTF1 NOL6 BAK1 PSMD2 CHD8 CHD1 PRPF8 PLXNB2 HNRNPF NSDHL CENPI PRKDC SYVN1 MED23 TOPORS | 1.96e-07 | 1203 | 134 | 19 | 29180619 |
| Pubmed | WASHC4 COPB1 SESN3 PSMD2 CHD9 SMARCAD1 ZNF224 LMO4 PRPF8 HNRNPF CCDC13 PDE4DIP FIBP CHD6 PRKDC WDFY3 EIF4G3 QTRT1 TARBP1 | 5.31e-07 | 1285 | 134 | 19 | 35914814 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TRIM25 WASHC4 CCT3 COPB1 NOL6 SMARCAD1 PRPF8 NCAPG2 HNRNPF THOC6 NSDHL LTN1 PRKDC EIF4G3 | 6.24e-07 | 704 | 134 | 14 | 29955894 |
| Pubmed | FAM114A1 CCT3 SPTA1 NOL6 GATB PSMD2 APOB PRPF8 HNRNPF THOC6 SPATC1 BMPR1A GTF2IRD2B BMPR1B GTF2IRD2 CHD6 EIF2AK4 PRKDC EIF4G3 PLIN1 | 7.03e-07 | 1442 | 134 | 20 | 35575683 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.56e-06 | 208 | 134 | 8 | 33230847 | |
| Pubmed | KLHL6 CLN8 RAPGEF6 AHCTF1 BBS4 APOB HNRNPF ZRANB3 BMPR1A LTN1 EIF2AK4 TNFAIP3 CPLANE1 FAM135A DSE DCP1A | 4.63e-06 | 1084 | 134 | 16 | 11544199 | |
| Pubmed | Trim25 Is an RNA-Specific Activator of Lin28a/TuT4-Mediated Uridylation. | 6.58e-06 | 10 | 134 | 3 | 25457611 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 7.18e-06 | 182 | 134 | 7 | 32239614 | |
| Pubmed | Endofin acts as a Smad anchor for receptor activation in BMP signaling. | 9.02e-06 | 11 | 134 | 3 | 17356069 | |
| Pubmed | CCT3 COPB1 AHCTF1 NOL6 PSMD2 CHD8 CHD1 PRPF8 HNRNPF GIGYF2 PRKDC EIF4G3 | 9.11e-06 | 653 | 134 | 12 | 22586326 | |
| Pubmed | 1.20e-05 | 12 | 134 | 3 | 19812316 | ||
| Pubmed | De novo genic mutations among a Chinese autism spectrum disorder cohort. | 1.20e-05 | 12 | 134 | 3 | 27824329 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.41e-05 | 202 | 134 | 7 | 33005030 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 7488101 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 22677273 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 9730621 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 10850425 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 28357470 | ||
| Pubmed | TRiC-P5, a novel TCP1-related protein, is localized in the cytoplasm and in the nuclear matrix. | 1.47e-05 | 2 | 134 | 2 | 7876352 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15322331 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 32764110 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 20673479 | ||
| Pubmed | Identification of the proteoglycan binding site in apolipoprotein B48. | 1.47e-05 | 2 | 134 | 2 | 12070165 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15102710 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 31255283 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 33990776 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 29349768 | ||
| Pubmed | BMPR1A and BMPR1B Missense Mutations Cause Primary Ovarian Insufficiency. | 1.47e-05 | 2 | 134 | 2 | 31769494 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 1.47e-05 | 2 | 134 | 2 | 15388857 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAPGEF6 TRIM25 CCT3 COPB1 ZFYVE16 AHCTF1 CHD1 PRPF8 HNRNPF GGA3 GIGYF2 PRKDC EIF4G3 DCP1A | 1.60e-05 | 934 | 134 | 14 | 33916271 |
| Pubmed | Proteomic analysis of the NOS2 interactome in human airway epithelial cells. | 1.66e-05 | 138 | 134 | 6 | 23438482 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TRIM25 WASHC4 CCT3 COPB1 AHCTF1 NOL6 PSMD2 CHD8 CHD1 SMARCAD1 PRPF8 NCAPG2 HNRNPF LTN1 PRKDC WDFY3 DCP1A | 1.86e-05 | 1353 | 134 | 17 | 29467282 |
| Pubmed | FAM114A1 PKD1L1 CHD8 CHD1 ZNF224 PLXNB2 GTF2IRD2B MICB HACE1 LTN1 ADAMTS20 COL14A1 EIF2AK4 EIF4G3 TRAPPC6A DCP1A | 1.90e-05 | 1215 | 134 | 16 | 15146197 | |
| Pubmed | 2.26e-05 | 87 | 134 | 5 | 20801516 | ||
| Pubmed | 2.54e-05 | 44 | 134 | 4 | 26471122 | ||
| Pubmed | DOCK4 ZFYVE16 SMARCAD1 GGA3 SRGAP3 PDE4DIP GIGYF2 CHD6 SYVN1 | 3.03e-05 | 407 | 134 | 9 | 12693553 | |
| Pubmed | ABCA13 AHCTF1 APOB HNRNPF PPM1B HACE1 KDM2B ADAMTS20 PRKDC DSE | 3.19e-05 | 513 | 134 | 10 | 25798074 | |
| Pubmed | 3.59e-05 | 48 | 134 | 4 | 26590968 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 3.87e-05 | 420 | 134 | 9 | 28065597 | |
| Pubmed | Age-Associated Increase in BMP Signaling Inhibits Hippocampal Neurogenesis. | 4.41e-05 | 3 | 134 | 2 | 25538007 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 24048844 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 15673568 | ||
| Pubmed | Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases. | 4.41e-05 | 3 | 134 | 2 | 12725532 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 16432712 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 8707881 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 11714695 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 23831617 | ||
| Pubmed | The type I BMP receptor ACVR1/ALK2 is required for chondrogenesis during development. | 4.41e-05 | 3 | 134 | 2 | 25413979 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 20363875 | ||
| Pubmed | BMP signaling specifies the development of a large and fast CNS synapse. | 4.41e-05 | 3 | 134 | 2 | 23708139 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 7750489 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 28533432 | ||
| Pubmed | BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. | 4.41e-05 | 3 | 134 | 2 | 20130193 | |
| Pubmed | Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours. | 4.41e-05 | 3 | 134 | 2 | 8605097 | |
| Pubmed | Role of type I receptors for anti-Müllerian hormone in the SMAT-1 Sertoli cell line. | 4.41e-05 | 3 | 134 | 2 | 15897891 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 32615282 | ||
| Pubmed | Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. | 4.41e-05 | 3 | 134 | 2 | 26584636 | |
| Pubmed | Expression of bone morphogenetic protein receptors in the developing mouse metanephros. | 4.41e-05 | 3 | 134 | 2 | 11701996 | |
| Pubmed | FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. | 4.41e-05 | 3 | 134 | 2 | 22349704 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 15100712 | ||
| Pubmed | Herp regulates Hrd1-mediated ubiquitylation in a ubiquitin-like domain-dependent manner. | 4.41e-05 | 3 | 134 | 2 | 21149444 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 19726563 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 12612194 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 19823864 | ||
| Pubmed | Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. | 4.41e-05 | 3 | 134 | 2 | 8592941 | |
| Pubmed | RAF1 RAPGEF6 NOL6 CHD8 SMARCAD1 NCAPG2 HNRNPF TGFBI GIGYF2 EIF2AK4 DDX11L8 | 4.61e-05 | 650 | 134 | 11 | 38777146 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.64e-05 | 430 | 134 | 9 | 35044719 | |
| Pubmed | 4.73e-05 | 244 | 134 | 7 | 28902428 | ||
| Pubmed | KLHL6 FOXO3 PROCR BAK1 PSMD2 CHD8 CHD1 NCAPG2 HNRNPF NSDHL CENPI FIBP GIGYF2 ECEL1 EIF2AK4 SYVN1 | 5.45e-05 | 1327 | 134 | 16 | 32694731 | |
| Pubmed | 6.11e-05 | 107 | 134 | 5 | 30995489 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | PROCR CHD8 APOB SS18 NCAPG2 TGFBI BMPR1A BMPR1B SLC15A4 PDE4DIP LTN1 SLC4A10 PRKDC WDFY3 | 6.37e-05 | 1061 | 134 | 14 | 33845483 |
| Pubmed | 7.07e-05 | 21 | 134 | 3 | 21571225 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | TRIM25 AFF2 CCT3 COPB1 SPTA1 VPS33A PSMD2 CHD8 PRPF8 HNRNPF NSDHL PRKDC | 7.15e-05 | 807 | 134 | 12 | 30575818 |
| Pubmed | 7.57e-05 | 263 | 134 | 7 | 34702444 | ||
| Pubmed | 7.92e-05 | 113 | 134 | 5 | 30352685 | ||
| Pubmed | Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells. | 8.80e-05 | 4 | 134 | 2 | 21152263 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 22293501 | ||
| Pubmed | Clinical perspectives on lupus genetics: advances and opportunities. | 8.80e-05 | 4 | 134 | 2 | 25034154 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 22971142 | ||
| Pubmed | GABAA-receptor alpha-subunit is an essential prerequisite for receptor formation in vivo. | 8.80e-05 | 4 | 134 | 2 | 9330366 | |
| Pubmed | FOXO3A directs a protective autophagy program in haematopoietic stem cells. | 8.80e-05 | 4 | 134 | 2 | 23389440 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 11401330 | ||
| Pubmed | HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression. | 8.80e-05 | 4 | 134 | 2 | 24904118 | |
| Pubmed | LTP of inhibition at PV interneuron output synapses requires developmental BMP signaling. | 8.80e-05 | 4 | 134 | 2 | 32572071 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 23229069 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 17913790 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 25376901 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 22899722 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 11282024 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 20587070 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 8392662 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 15235019 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 28424160 | ||
| Pubmed | A GDF5 point mutation strikes twice--causing BDA1 and SYNS2. | 8.80e-05 | 4 | 134 | 2 | 24098149 | |
| Pubmed | The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signaling. | 8.80e-05 | 4 | 134 | 2 | 26701726 | |
| Pubmed | Chromosomal localization of three human genes encoding bone morphogenetic protein receptors. | 8.80e-05 | 4 | 134 | 2 | 10051328 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 8389469 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 8146195 | ||
| Interaction | OPALIN interactions | 1.29e-06 | 209 | 133 | 10 | int:OPALIN | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 4.95e-04 | 7 | 89 | 2 | 345 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.38e-07 | 193 | 135 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 167 | 135 | 6 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 169 | 135 | 6 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.38e-05 | 171 | 135 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 175 | 135 | 6 | 69b59ec58e64644deb7e07f31ef495ef4a6f6276 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 175 | 135 | 6 | 4f7498b5a0ed52c348a5f94bcd41d830ba7954ea | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.85e-05 | 180 | 135 | 6 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-05 | 183 | 135 | 6 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 192 | 135 | 6 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.82e-05 | 194 | 135 | 6 | 935ec4554d740935d9d9a59d9d6b5293d1c27d1f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 197 | 135 | 6 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.16e-05 | 198 | 135 | 6 | 1fe60443c11d34b6d2671af8f06e0dedc8d1558b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 198 | 135 | 6 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 3.25e-05 | 199 | 135 | 6 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 3.25e-05 | 199 | 135 | 6 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.25e-05 | 199 | 135 | 6 | 614c1e788d89310e78984241977941beed8d12dc | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.34e-05 | 200 | 135 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.34e-05 | 200 | 135 | 6 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.34e-05 | 200 | 135 | 6 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.34e-05 | 200 | 135 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 3.09e-06 | 7 | 133 | 3 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Disorder of eye | 5.18e-05 | 212 | 133 | 7 | C0015397 | |
| Disease | basophil percentage of leukocytes | 1.22e-04 | 243 | 133 | 7 | EFO_0007992 | |
| Disease | cholesterol to total lipids in medium LDL percentage | 2.42e-04 | 27 | 133 | 3 | EFO_0022238 | |
| Disease | basophil count | 3.56e-04 | 483 | 133 | 9 | EFO_0005090 | |
| Disease | Pilomyxoid astrocytoma | 4.17e-04 | 7 | 133 | 2 | C1519086 | |
| Disease | mosaic loss of chromosome Y measurement | 4.79e-04 | 80 | 133 | 4 | EFO_0007783 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.43e-04 | 152 | 133 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Schizophrenia | DOCK4 RAPGEF6 DYM ADAMTS3 ABCA13 SRD5A2 R3HDML PTPRZ1 SRGAP3 MICB KDM2B GABRA5 | 6.71e-04 | 883 | 133 | 12 | C0036341 |
| Disease | Idiopathic pulmonary hypertension | 7.11e-04 | 9 | 133 | 2 | C0152171 | |
| Disease | degree of unsaturation measurement | 7.27e-04 | 39 | 133 | 3 | EFO_0022261 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 8.86e-04 | 10 | 133 | 2 | OBA_2045163 | |
| Disease | triacylglycerol 56:6 measurement | 9.68e-04 | 43 | 133 | 3 | EFO_0010433 | |
| Disease | cytochrome p450 3a4 measurement | 1.08e-03 | 11 | 133 | 2 | EFO_0020303 | |
| Disease | triacylglycerol 56:2 measurement | 1.08e-03 | 11 | 133 | 2 | EFO_0010429 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 1.08e-03 | 11 | 133 | 2 | OBA_2045170 | |
| Disease | lysophosphatidylcholine 20:2 measurement | 1.08e-03 | 11 | 133 | 2 | EFO_0021458 | |
| Disease | Gastric Adenocarcinoma | 1.11e-03 | 45 | 133 | 3 | C0278701 | |
| Disease | vitamin D measurement, COVID-19 | 1.42e-03 | 49 | 133 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | sexual dimorphism measurement | FOXO3 RAPGEF6 DYM ADAMTS3 PROCR VPS33A APOB NDRG3 FRK ZPR1 KCNQ1 LILRA5 DSE | 1.51e-03 | 1106 | 133 | 13 | EFO_0021796 |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.52e-03 | 13 | 133 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | corneal topography | 1.52e-03 | 109 | 133 | 4 | EFO_0004345 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.59e-03 | 51 | 133 | 3 | EFO_0022302 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.77e-03 | 14 | 133 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | serum alanine aminotransferase measurement | FOXO3 RAPGEF6 PROCR PKD1L1 SRD5A2 SRMS APOB PLXNB2 FRK TAS2R16 LTN1 | 1.97e-03 | 869 | 133 | 11 | EFO_0004735 |
| Disease | low density lipoprotein triglyceride measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0009946 | |
| Disease | triacylglycerol 52:3 measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0010415 | |
| Disease | cholesterol to total lipids in large LDL percentage | 2.08e-03 | 56 | 133 | 3 | EFO_0022235 | |
| Disease | Idiopathic pulmonary arterial hypertension | 2.32e-03 | 16 | 133 | 2 | C3203102 | |
| Disease | Eye Abnormalities | 2.62e-03 | 17 | 133 | 2 | C0015393 | |
| Disease | protein C measurement | 2.62e-03 | 17 | 133 | 2 | EFO_0004633 | |
| Disease | Astigmatism | 2.81e-03 | 129 | 133 | 4 | HP_0000483 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 2.94e-03 | 18 | 133 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.28e-03 | 19 | 133 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 3.28e-03 | 19 | 133 | 2 | EFO_0802076 | |
| Disease | venous thromboembolism, fibrinogen measurement | 3.47e-03 | 67 | 133 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | dehydroepiandrosterone sulphate measurement | 3.62e-03 | 68 | 133 | 3 | EFO_0007001 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 3.63e-03 | 20 | 133 | 2 | OBA_2045071 | |
| Disease | congenital heart disease (implicated_via_orthology) | 3.78e-03 | 69 | 133 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | neutrophil percentage of granulocytes | 3.81e-03 | 228 | 133 | 5 | EFO_0007994 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 4.00e-03 | 21 | 133 | 2 | OBA_2045156 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 4.00e-03 | 21 | 133 | 2 | EFO_0022262 | |
| Disease | eosinophil percentage of granulocytes | 4.25e-03 | 234 | 133 | 5 | EFO_0007996 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITRQQNYHSMESILQ | 411 | Q8TAA9 | |
| SNVNIELLNALRYHM | 161 | Q15582 | |
| ASDGLQRLHMLQISY | 21 | Q9UNN8 | |
| ALNLNRHDLTYIMLG | 161 | Q96RK4 | |
| LLISTLHGTYQNLNM | 671 | Q9HCE6 | |
| TIVYHGSLASRQMIQ | 886 | Q9HCK8 | |
| LQERNYSIYLNHTML | 1191 | Q9P2K8 | |
| NRRYDSEFQTMLQHL | 86 | Q16611 | |
| QLVLYMGILLSHANS | 261 | P0DMS8 | |
| QHSSMTNLVRYVRQG | 1286 | P51816 | |
| TSQPRLETVQQHLYM | 3026 | Q86UQ4 | |
| QQYGMLLEHSFTLLN | 386 | O75879 | |
| LNEMNTLRTQCGHLY | 211 | O76090 | |
| NSRVTQLYMQLLHEI | 131 | Q9UKU9 | |
| DGISRYMEGQVLHLQ | 1461 | Q96PN6 | |
| EIYQTVLMRHENILG | 246 | O00238 | |
| GFTIVNRLNMHNLVE | 66 | Q9NPI6 | |
| YLGDINSRNMIRTHE | 561 | O14646 | |
| GSNLQNYILTLMSIV | 276 | P59510 | |
| IDIARQTAQGMDYLH | 446 | P04049 | |
| LPYSHINNRDQIIFM | 546 | P04049 | |
| LLMAHQYLRGSVETQ | 316 | Q04671 | |
| RLNLLQSHPQEVMYF | 301 | Q9NXS2 | |
| LQLSTYLTHQNGSIM | 1681 | O94822 | |
| ANLDLIQTYRMHIAQ | 201 | Q9UGV2 | |
| MAGLHYSTCLQRQIQ | 741 | Q6ZMT4 | |
| VIEQYSQGHLNLMVR | 541 | P51787 | |
| SHLQDYAVENLIRMG | 256 | A6NI73 | |
| LQEARMYHLSGNEII | 291 | Q8WZ60 | |
| MILYDLQQNLSSSHR | 376 | O15554 | |
| ASELVMRAQGNVYHL | 96 | P61968 | |
| EHQGNVMIVRRYSIS | 76 | A0A1B0GUA6 | |
| YMDLQNDLGQTALHL | 86 | Q15653 | |
| QSGQIYSEMIHNLLR | 1446 | Q9P2D6 | |
| RVNTLMHYNVRDGAT | 1541 | O15031 | |
| YRLGLGHNQIRMIEN | 256 | P21810 | |
| NTNMVDLNDYLQHIL | 856 | P53618 | |
| YHPRLFQTIIQMTQN | 251 | Q8IYU2 | |
| MLLETDHINQIGYRV | 796 | Q9ULK4 | |
| HTTMSGYQVLRSVLQ | 366 | Q9H6R4 | |
| LAMQLTYFQRAQSLH | 916 | Q9UL01 | |
| MGNQLDRITHLNYSE | 1 | Q96KN4 | |
| VNNNVRLLSEMLLHY | 221 | Q9NZ52 | |
| RLNQYHLMGQTVGTE | 221 | P31644 | |
| HSLRYNLMVLSQDGS | 26 | Q29980 | |
| GTYIVLDSMLQQIQH | 1941 | P23471 | |
| YMQQVSQLIRSTPHR | 381 | O95672 | |
| RYTVQTMARALEQGH | 231 | O60240 | |
| TELMRHGSLQEYLQN | 306 | P42685 | |
| SQELQQIHQYIMALR | 4371 | P04114 | |
| HVQNYLLTLMNIVNE | 276 | O15072 | |
| VVYHGSLISRQMIQQ | 936 | Q3L8U1 | |
| HLLRSTGNTQVEYMI | 526 | A0AVF1 | |
| QRSHLTQEYQRESML | 376 | Q8NHM5 | |
| SLLRQMTDRHYQQLL | 921 | Q8N1I0 | |
| TRQQELTALYQMQHL | 611 | Q6Y7W6 | |
| GHMIRLYTNKNSTLN | 61 | Q9UBX8 | |
| IYQRNAPNHMELTSI | 1491 | Q9H799 | |
| LHQNSNIRTYMLART | 356 | Q7RTS9 | |
| EIISHQYRMQIAQRS | 286 | A8K855 | |
| AIVYHGSQISRQMIQ | 536 | Q8TD26 | |
| QLIQSHMARYTAILN | 1626 | Q05707 | |
| QLEMEIGQLNVHYLR | 446 | Q8IYE1 | |
| YQMLLHAATRQAAGI | 371 | A8MPP1 | |
| EIYQTVLMRHENILG | 276 | P36894 | |
| IMLQNNEHRIAQYLA | 241 | P56202 | |
| HLELQVNRTYQMHLG | 166 | Q8N6P7 | |
| MSQGEHRQALRYIQT | 851 | Q8WYP5 | |
| SQMGSVLNNSLLLHY | 361 | Q92674 | |
| QGHSQIVTQMYDLIR | 771 | Q86UP8 | |
| QGHSQIVTQMYDLIR | 771 | Q6EKJ0 | |
| FQMQTTYVLQSLHLR | 336 | Q8N697 | |
| QITRDHMGQLLYQLV | 1271 | O43432 | |
| QMEFRTLLHYNLQSS | 1466 | Q8TDX9 | |
| SQLMRYVGQNLSIHS | 111 | Q9H3Y0 | |
| RLAQQLTMERTAHYG | 276 | Q8IWE2 | |
| QQHSLNLRYGMETTS | 261 | Q3ZCT8 | |
| YMVNNRNHGLDLRLV | 271 | P03999 | |
| MRGSLVDNIQQHFLL | 151 | O43427 | |
| NMQHRYIELFLNSTT | 351 | P52597 | |
| SMSHYGNQTLQDLLT | 461 | O43524 | |
| IGNYIQIQLLTMEHL | 146 | Q9NYV7 | |
| HTLLDAAMLQINQYL | 511 | Q86TM6 | |
| YRNQGNLMKLNSHLS | 491 | A2RUB1 | |
| SLGNQHIYQRSSSML | 526 | Q8IWZ5 | |
| YLHGMEILSNLREHQ | 31 | Q8TEU7 | |
| TVHNIAYQLQLMSAV | 346 | Q9BXR0 | |
| YQHLMTINANNRLLL | 641 | Q9H4L7 | |
| TILSGYHRIVQQRMQ | 61 | Q9NW38 | |
| LSDYVLHNSNTMRLG | 466 | Q13200 | |
| MADLHRQLQEYLAQG | 1 | Q587I9 | |
| LTKNSVRIGQLMHYD | 116 | O43173 | |
| ISDLAQHYLMRANIT | 296 | P49368 | |
| QHMVEQLLARGYAVN | 51 | Q15738 | |
| INHRGNYRQLLEEML | 401 | O75688 | |
| TNHETLQQIMRGYRL | 431 | Q9H3Y6 | |
| MEIEINYLNQQISRH | 216 | Q8N1H7 | |
| VNLQAGHYLAMTTLL | 151 | Q9UBY8 | |
| LGDHQFQMQLLQRSL | 896 | Q86XI2 | |
| DMNHTNSYGIIRGLQ | 1021 | Q6P2Q9 | |
| HYNRTRQQEEMLGLQ | 221 | O75312 | |
| TQHIALTQNVITYMR | 121 | Q8TC21 | |
| VMLENFRNLLSVGHQ | 36 | Q9UK11 | |
| VMLENYRNLVSLGGH | 56 | Q86YE8 | |
| GEISNFQYLMHLNTL | 2701 | Q8IZQ1 | |
| HLNTLAGRSYNDLMQ | 2711 | Q8IZQ1 | |
| LQISHMTQADLYRVN | 131 | Q99973 | |
| MARSGLQYNSLEEIH | 181 | P21580 | |
| SAQQPVQTELLMRYH | 346 | O43295 | |
| VQTELLMRYHQLQSR | 351 | O43295 | |
| MSLLTNYEGLRHQIE | 1 | Q76KD6 | |
| SNMQRYDLASHLGIR | 731 | Q5TF21 | |
| RLDNITQVMSLHTQY | 71 | P58005 | |
| HNTYLVGDQLMSQSR | 341 | O75038 | |
| QQMLHTNLVYLATIA | 51 | Q15532 | |
| TLRHKLTVMYSQING | 201 | Q14258 | |
| GQQYHEIGRSIATLM | 381 | Q6U841 | |
| LGQTEVFQALQRLHM | 11 | Q86W42 | |
| GMGINIHSDYILRQL | 156 | P31213 | |
| QELQERPSQRHQMLY | 141 | Q9Y2I9 | |
| YQLGLRMQHNLEQQI | 2246 | P02549 | |
| QMDSLRTNHQGTYVL | 81 | O75865 | |
| MQNYSSIDVLLHQSR | 3111 | P78527 | |
| VMLENFRNLLSVGHQ | 36 | Q9UK10 | |
| NIVQHIIMSNVTRYD | 316 | Q9NS56 | |
| NLATQRYGLVMTEAH | 756 | Q2M389 | |
| VMLENFRNLLSVGHQ | 36 | Q12901 | |
| ITVYNTNIDNRHEML | 406 | Q8NET8 | |
| LQISLGLNYIHNSSM | 321 | P0C1S8 | |
| NYILIMETLEGNQIH | 331 | Q13395 | |
| MAAHLSYGRVNLNVL | 1 | Q96AX1 | |
| YLLMDRVSQILQDHG | 36 | Q3SY77 | |
| VMLENFRNLLSVGHQ | 36 | Q9NZL3 | |
| MLNGQEVRLTIHYEN | 451 | Q13425 | |
| ISLYNTLAQHNTRML | 1071 | Q5TAX3 | |
| IGHTIMNLLVDLRNY | 1221 | Q7Z3T8 | |
| VMLENFRNLLSVGHQ | 36 | Q2VY69 | |
| LVLTSHRGIQMYESN | 86 | Q9H977 | |
| NIHYLIANGTLDTLM | 441 | Q5FWF4 | |
| LNEAGMVHNLLIRYQ | 76 | Q6PIF6 | |
| MSNGYRTLSQHLNDL | 1 | Q5VU43 |